TY - JOUR T1 - Biotransformation of <span class="sc">l</span>-Cysteine<em>S</em>-Conjugates and<em>N</em>-Acetyl-<span class="sc">l</span>-Cysteine<em>S</em>-Conjugates of the Sevoflurane Degradation Product Fluoromethyl-2,2-Difluoro-1-(trifluoromethyl)vinyl Ether (Compound A) in Human Kidney in Vitro: Interindividual Variability in<em>N</em>-Acetylation, <em>N</em>-Deacetylation, and β-Lyase-Catalyzed Metabolism JF - Drug Metabolism and Disposition JO - Drug Metab Dispos SP - 148 LP - 154 DO - 10.1124/dmd.30.2.148 VL - 30 IS - 2 AU - T. Gul Altuntas AU - Evan D. Kharasch Y1 - 2002/02/01 UR - http://dmd.aspetjournals.org/content/30/2/148.abstract N2 - Fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (FDVE; 1) is a fluoroalkene formed by the base-catalyzed degradation of the anesthetic sevoflurane. FDVE is nephrotoxic in rats. In both rats and humans, FDVE undergoes glutathione-dependent conjugation, cleavage to cysteine S-conjugates, and renal β-lyase-catalyzed metabolism to reactive intermediates, which may cause nephrotoxicity. Interindividual variability in renal metabolism of FDVE is unknown. Therefore, this investigation quantified β-lyase-catalyzed bioactivation and N-acetyltransferase-catalyzed inactivation of FDVE cysteine S-conjugates and reactivation of mercapturates by N-deacetylase in cytosol and microsomes from 20 human kidneys. In cytosol,N-acetylation ranged from 0.008 to 0.045 (0.024 ± 0.01) nmol of mercapturate/mg/min and 0.001 to 0.07 (0.024 ± 0.02) nmol of mercapturate/mg/min for alkane and alkene cysteineS-conjugates, respectively. Similar results for microsomal N-acetylation were obtained;N-acetylation ranged from 0.005 to 0.055 (0.025 ± 0.02) nmol of mercapturate/mg/min and 0.001 to 0.06 (0.030 ± 0.02) nmol of mercapturate/mg/min for alkane and alkene cysteineS-conjugates, respectively. β-Lyase-catalyzed metabolism to pyruvate varied from 0.004 to 0.14 (0.051 ± 0.04) nmol/mg/min and from 0.10 to 0.40 (0.26 ± 0.08) nmol/mg/min for alkane and alkene cysteine-S-conjugates, respectively.N-deacetylation of mercapturates ranged from 0.8 to 2.5 (1.25 ± 0.57) nmol of cysteine S-conjugate formed/mg/min and 0.05 to 0.37 (0.17 ± 0.10) nmol of cysteineS-conjugate formed/mg/min for alkane and alkene FDVE mercapturates. Cytosolic cysteine S-conjugates metabolism by renal β-lyase predominated overN-acetylation (ratio of activities was 0.2–6 and 3–146 for the alkane and alkene cysteine S-conjugates).N-deacetylation predominated overN-acetylation (ratio of activities was 20–205 and 2–54 for alkane and alkene S-conjugates). There was considerable (up to 50-fold) interindividual variability in rates of FDVE toxication (β-lyase metabolism andN-deacetylation) and detoxication. This interindividual variability may effect individual susceptibility to the nephrotoxicity of FDVE and other haloalkenes. The American Society for Pharmacology and Experimental Therapeutics ER -